IJSRP Logo
International Journal of Scientific and Research Publications

IJSRP, Volume 3, Issue 8, August 2013 Edition [ISSN 2250-3153]


Anti-Angiogenic Effects of Diltiazem, Imatinib, and Bevacizumab in the CAM Assay
      Caglar Yildiz, Ali Cetin, Fatih Demirci, Zubeyde Akin Polat, Tuba Kiyan, Ahmet Altun, Meral Cetin, Ozlem Kayim Yildiz, Ismihan Goze
Abstract: Angiogenesis that plays important roles in a variety of physiological processes is strictly delimited and finely tuned by a balance of pro-angiogenic and anti-angiogenic factors. Angiogenesis is essential for viability, growth, invasion and metastasis of tumors. The chorioallantoic membrane model is considered to be a valuable method for investigation of anti-angiogenic effects of drugs and other substances. The aim of the present study is to investigate the anti-angiogenic effects of a calcium channel blocker (diltiazem), a tyrosine kinase inhibitor (imatinib), and a vascular endothelial growth factor inhibitor (bevacizumab) with the means of the chicken chorioallantoic membrane (CAM) model.

Reference this Research Paper (copy & paste below code):

Caglar Yildiz, Ali Cetin, Fatih Demirci, Zubeyde Akin Polat, Tuba Kiyan, Ahmet Altun, Meral Cetin, Ozlem Kayim Yildiz, Ismihan Goze (2018); Anti-Angiogenic Effects of Diltiazem, Imatinib, and Bevacizumab in the CAM Assay; Int J Sci Res Publ 3(8) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0813.php?rp=P201629
©️ Copyright 2011-2023 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.